Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-13

Clinical Trial Update: Melatonin Use in Patients With Climacterious Symptoms in the Perimenopause [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 clinical trial evaluating melatonin for climacteric/perimenopausal symptoms in individuals with Perimenopausal Di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Univates | Conditions: Perimenopausal Disorder | Phase 2 | Status: COMPLETED